No abstract available
Plain language summary
This cross-sectional study evaluates the use of the US Food and Drug Administration’s Real-Time Oncology Review (RTOR) program in confirming the effectiveness of cancer drugs.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Drug Approval*
-
Humans
-
Medical Oncology
-
Neoplasms / drug therapy
-
Product Surveillance, Postmarketing* / methods
-
Product Surveillance, Postmarketing* / standards
-
Product Surveillance, Postmarketing* / statistics & numerical data
-
United States
-
United States Food and Drug Administration*